SOD1 and amyotrophic lateral sclerosis: Additionally, significant benefits were observed with the intrathecal administration of a miR-124-depleted secretome in a mouse model of amyotrophic lateral sclerosis (SOD1-G93A), preventing neurodegeneration and glial dysfunction, along with a marked delay in disease progression [120].